What are the current guidelines for the management of splenic artery aneurysm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Splenic Artery Aneurysms

Splenic artery aneurysms ≥2 cm in diameter should be treated prophylactically, with endovascular intervention as the preferred first-line approach in stable patients, while all women of childbearing age and pregnant women with known splenic artery aneurysms should undergo prophylactic treatment regardless of size due to catastrophic maternal (70%) and fetal (>90%) mortality rates if rupture occurs. 1

Size Thresholds for Intervention

General Population

  • Asymptomatic aneurysms ≥2 cm require treatment 1
  • Aneurysms <2 cm can be observed with serial imaging, though 50% of ruptures during pregnancy occur at sizes <2 cm 2, 3
  • Growth rates are slow: 0.17 mm/year for aneurysms 10-19 mm, and 0.38 mm/year for 20-29 mm aneurysms 4
  • Symptomatic aneurysms (chronic upper abdominal pain) warrant treatment regardless of size 1

High-Risk Populations Requiring Lower Treatment Thresholds

Women of childbearing age (15-50 years):

  • Prophylactic intervention should be performed for any known splenic artery aneurysm, even if <2 cm 1, 5
  • Maternal mortality from rupture reaches 70% and fetal mortality exceeds 90% 1
  • Risk is highest in the third trimester when hyperdynamic circulation maximizes splenic blood flow 2

Pregnant women with known aneurysms:

  • Prophylactic intervention is appropriate if the aneurysm has previously ruptured or is >2-3 cm pre-conception 2
  • Up to 50% of ruptures occur at sizes <2 cm, making definitive size recommendations difficult for smaller aneurysms 2

Liver transplant candidates with cirrhosis:

  • Treatment should be considered regardless of aneurysm size due to heightened rupture risk perioperatively 6
  • Portal hypertension increases splenic artery aneurysm prevalence and rupture risk 2, 3, 6
  • Post-transplant rupture occurred in 4.7% of untreated patients (50% mortality) versus 7.1% of surgically treated patients (0% mortality) 6

Treatment Modalities

Endovascular Treatment (First-Line)

Endovascular intervention is preferred for stable patients with mortality rates of 0.5% versus 4.9% for open surgery 7

Technical approaches include: 8

  • Dense embolization of the aneurysm sac and outflow artery
  • Coil embolization with or without inflow artery treatment
  • Covered stent placement for specific anatomic configurations
  • Technical success rates reach 95.5% with 95.5% complete thrombosis at mean 34-month follow-up 8

Indications for endovascular approach: 9, 7

  • Stable aneurysms >2 cm in elective settings
  • Anatomically favorable locations (distal, mid-splenic artery)
  • Patients with significant surgical comorbidities

Open Surgical Treatment

Reserved for specific scenarios: 9, 7

  • Ruptured aneurysms with hemodynamic instability
  • Failed endovascular attempts
  • Proximal aneurysms at the splenic artery origin
  • Complex anatomy unsuitable for endovascular repair

Surgical options include: 1

  • Aneurysm ligation
  • Aneurysmectomy with or without splenectomy
  • Prosthetic replacement grafting
  • Elective surgical mortality is 0% versus 38% for ruptured aneurysms 1

Management of Acute Rupture

For ruptured aneurysms presenting with abdominal pain and syncope: 2

  • Transcatheter embolization is the mainstay of treatment
  • Surgical arterial ligation and splenectomy reserved for failed endovascular therapy
  • Watch for "double rupture phenomenon" (25% of cases): initial herald bleed followed by major rupture with hemorrhagic shock 2
  • Non-pregnant rupture mortality: 10-25%; pregnant rupture mortality: up to 70% 1

Surveillance Strategy

Imaging Follow-up for Untreated Aneurysms

  • Serial CT or ultrasound imaging for aneurysms <2 cm 1
  • Doppler ultrasound and contrast-enhanced ultrasound useful for evaluating splenic vascularization 10
  • Mean radiological follow-up demonstrates 23.7% experience growth over 3.8 years 4
  • Prior tobacco use significantly associated with aneurysm growth (p=0.028) 4

Post-Intervention Surveillance

  • Regular imaging critical to detect complications including pseudoaneurysm formation 10
  • Reintervention needed in 4.5% of endovascular cases for persistent sac enlargement 8
  • Covered stent occlusion occurs in 11% but typically asymptomatic 8

Common Pitfalls and Caveats

Critical considerations:

  • Most splenic artery aneurysms (80%) are asymptomatic at diagnosis, discovered incidentally on abdominal imaging 1
  • The 2 cm threshold is not absolute—50% of pregnancy-related ruptures occur below this size 2, 3
  • Men and patients with non-calcified aneurysms have higher rupture risk 1
  • Beta-blockade may be protective—no ruptured aneurysms occurred in patients receiving beta-blockers in one series 1
  • Attention to splenic artery aneurysms is appropriate in women with severe splenomegaly from portal hypertension 2

Post-splenectomy considerations if performed:

  • Vaccination against encapsulated bacteria (S. pneumoniae, H. influenzae, N. meningitidis) starting ≥14 days post-procedure 10
  • Immunization against seasonal influenza for patients >6 months of age 10
  • Antibiotic therapy for any sudden unexplained fever or constitutional symptoms 10

References

Research

Endovascular and surgical management of splenic artery aneurysms.

Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.